Compound Detail
CHEMBL9194
ATRASENTAN 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1
Basic Information
| ChEMBL ID | CHEMBL9194 |
| Name | ATRASENTAN |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | MOTJMGVDPWRKOC-QPVYNBJUSA-N |
7
Targets
30
Activities
3
Assay Types
12
PK Parameters
20
Publications
1
Known Names
5
Indications
Molecular Properties
510.6
MW (Da)
4.69
ALogP
6
HBA
1
HBD
88.5
PSA (Ų)
0.44
QED
1
Ro5 Violations
12
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Diabetic Nephropathies Glomerulonephritis, IGA Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Renal Insufficiency, Chronic
Activity Summary
IC50 22 meas. best 10.47
Ki 6 meas. best 10.47
Kd 2 meas. best 8.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Endothelin-1 receptor CHEMBL252 | IC50 | 10.47 | 10.125 | 0.0 | 8 |
| Endothelin-1 receptor CHEMBL252 | Ki | 10.47 | 10.47 | 0.0 | 3 |
| Endothelin-1 receptor CHEMBL4566 | Ki | 10.47 | 10.4 | 0.0 | 2 |
| Endothelin receptor CHEMBL2111453 | IC50 | 10.4 | 10.4 | 0.0 | 1 |
| Endothelin-1 receptor CHEMBL4566 | IC50 | 10.1 | 9.4633 | 0.1 | 6 |
| Rattus norvegicus CHEMBL376 | Kd | 8.6 | 8.6 | 2.5 | 1 |
| Endothelin receptor type B CHEMBL1785 | IC50 | 7.2 | 6.905 | 63.3 | 4 |
| Endothelin receptor type B CHEMBL1785 | Ki | 7.2 | 7.2 | 63.3 | 1 |
| Endothelin receptor type B CHEMBL3949 | IC50 | 6.96 | 6.6533 | 110.0 | 3 |
| Oryctolagus cuniculus CHEMBL374 | Kd | 6.1 | 6.1 | 794.3 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 10666.67 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 5833.33 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 7.36 | ug ml-1 | - |
| Cmax | 6266.77 | nM | Rattus norvegicus |
| Cmax | 6736.78 | nM | - |
| F | 70.0 | % | Rattus norvegicus |
| F | 68.0 | % | Rattus norvegicus |
| F | 60.2 | % | Eutheria |
| T1/2 | 3.5 | hr | Rattus norvegicus |
| T1/2 | 3.5 | hr | - |
| T1/2 | 3.5 | hr | - |
| T1/2 | 6.2 | hr | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11689084 | 10.1021/jm010237l | ADMET | 5 |
| 12193066 | 10.1042/cs103s107s | Endothelin-1 receptor | 4 |
| 11689084 | 10.1021/jm010237l | Endothelin-1 receptor | 3 |
| 12193066 | 10.1042/cs103s107s | Endothelin receptor type B | 3 |
| 9022798 | 10.1021/jm960077r | Rattus norvegicus | 3 |
| 15055997 | 10.1021/jm030528p | Rattus norvegicus | 2 |
| 27266371 | 10.1021/acs.jmedchem.5b01781 | Endothelin-1 receptor | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 11689084 | 10.1021/jm010237l | Endothelin receptor type B | 2 |
| 8676339 | 10.1021/jm9505369 | Endothelin-1 receptor | 2 |
| 9022798 | 10.1021/jm960077r | ADMET | 2 |
| 15055997 | 10.1021/jm030528p | Endothelin-1 receptor | 2 |
| 8676339 | 10.1021/jm9505369 | Endothelin receptor type B | 1 |
| 8676339 | 10.1021/jm9505369 | Endothelin receptor | 1 |
| 10479298 | 10.1021/jm990170q | Endothelin-1 receptor | 1 |
| 10479299 | 10.1021/jm990171i | Endothelin-1 receptor | 1 |
| 12193066 | 10.1042/cs103s107s | Unchecked | 1 |
| 9022798 | 10.1021/jm960077r | Endothelin-1 receptor | 1 |
| 9379441 | 10.1021/jm970101g | ADMET | 1 |
| 9379441 | 10.1021/jm970101g | Endothelin-1 receptor | 1 |
Data from ChEMBL 36 via Core Engine